Related Experiment Video

Updated: May 11, 2026

Modeling Cataract Surgery in Mice
05:19

Modeling Cataract Surgery in Mice

Published on: December 1, 2023

Visual outcome of cataract in pediatric age group: does etiology have a role

Mehul A Shah1, Shreya M Shah, Ashit H Shah

  • 1Drashti Netralaya, Dahod, Gujarat - India.

European Journal of Ophthalmology
|May 28, 2013
PubMed

Insights

Pediatric cataract surgery outcomes were compared between traumatic and nontraumatic groups. Nontraumatic cataracts showed significantly better visual outcomes post-surgery.

Area of Science:

  • Ophthalmology
  • Pediatric Surgery
  • Visual Rehabilitation

Background:

  • Unilateral cataracts in children under 5 present unique challenges.
  • Traumatic cataracts require specific management considerations.

Purpose of the Study:

  • To compare visual outcomes in pediatric patients with traumatic versus nontraumatic cataracts.
  • Evaluate the effectiveness of surgical intervention for various pediatric cataract types.

Main Methods:

  • Retrospective cohort study of 128 pediatric eyes (under 5 years) with unilateral cataracts.
  • Patients categorized into traumatic (85 eyes) and nontraumatic (43 eyes) groups.
  • Analysis of demographics, cataract type, surgical intervention, and postoperative visual acuity.

Main Results:

  • A total of 128 children under 5 years with unilateral cataracts were analyzed.
  • Visual acuity better than 20/200 was achieved by 51.1% of the traumatic group and 47.1% of the nontraumatic group.
  • A statistically significant difference in visual outcome was noted between the groups.

Conclusions:

  • Intraocular lens implantation is effective for visual rehabilitation in pediatric cataracts.
  • Nontraumatic pediatric cataracts yield significantly better visual outcomes compared to traumatic ones.
  • Early surgical intervention is crucial for optimal visual results in pediatric cataract patients.
Abstract

More Related Videos

Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract13:56

Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract

Published on: November 28, 2012

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...